Search clinical trials for: anti-EGFR monoclonal antibody

Total 6511 results

Oslo University Hospital

Completed

Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma

Mantle Cell Lymphoma

Norway
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Novartis Pharmaceuticals

Completed

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Advanced Age-related Macular Degeneration

United States
Abbott
Biogen

Terminated

A Study of Volociximab in Metastatic Melanoma

Stage IV Melanoma

United States
Institute of Hematology & Blood Diseases Hospital

Unknown

Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.

Pathologic Processes | Immune System Diseases | Autoimmune Diseases | Hematologic Diseases | Anemia | Anemia, Hemolytic | Hemolysis | Anemia, Hemolytic, Autoimmune

China
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Chlamidia Antibodies Test for Tubal Factor Screening

Sterility

Spain
Université de Sherbrooke

Completed

Study of Cervix and Inflammation in Preterm Birth Prediction (COLIBRI)

Preterm Birth

Canada
Radboud University Medical Center

Completed

Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer (PRIT2008)

Colorectal Neoplasms

Netherlands
Pfizer

Completed

Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.

Pneumococcal Disease | 13-valent Pneumococcal Vaccine

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Lymphoma | Leukemia | Chronic Myeloproliferative Disorders | Precancerous Condition | Nonneoplastic Condition

United States
Pfizer

Terminated

Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People

Healthy

United States
Meir Medical Center

Unknown

Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy Peoples (SSc)

Scleroderma
Regeneron Pharmaceuticals
Sanofi

Completed

Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN668 Administered Subcutaneously to Healthy Volunteers

Healthy

United States
Pharming Technologies B.V.
University of Wisconsin, Madison

Withdrawn

Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation

Kidney Transplantation | Graft Rejection

United States
Novartis Vaccines

Completed

Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children

Prevention of Meningococcal Infection

Germany, Poland
Pfizer

Completed

Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.

Safety | Immunization | 13-valent Pneumococcal Vaccine | Antibody Response

France
Sahlgrenska University Hospital, Sweden

Completed

Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients

Organ Transplantation

Sweden
Federal University of Uberlandia
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Completed

Sublingual Immunotherapy in Children With Allergic Rhinitis (SLIT)

Allergic Rhinitis

Brazil
Abbott

Completed

A Trial of PDL192 in Subjects With Advanced Solid Tumors

Cancer

United States
Seoul National University Hospital
Roche Pharma AG

Unknown

Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant

End Stage Renal Disease

Korea, Republic of
Novartis Vaccines

Completed

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects

Influenza

United Kingdom
CABYC
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Completed

Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02) (LCM-04-02)

Mantle Cell Lymphoma

Spain
Novartis Vaccines

Completed

Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants

Haemophilus Influenzae Type b (Hib) Infection

China
Bristol-Myers Squibb

Withdrawn

Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma (PD-L1)

Stage III or IV Melanoma
Sanofi

Completed

Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine

Hepatitis B | Whooping Cough | Tetanus | Diphtheria | Poliomyelitis

South Africa
Neovii Biotech
University Medical Center Freiburg

Completed

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

Graft vs Host Disease

Germany
Novartis Vaccines

Completed

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

Tick Borne Encephalitis (TBE)

Germany
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Small Intestine Cancer | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Precancerous/Nonmalignant Condition

United States
Fernando Fervenza
Genentech, Inc.; Biogen; National Center for Research Resources (NCRR)

Terminated

Rituxan in Churg Strauss Syndrome With Renal Involvement

Churg-Strauss Syndrome

United States
Bristol-Myers Squibb

Withdrawn

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Melanoma

United States
Amgen Research (Munich) GmbH

Completed

Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases (MT201-204)

Colorectal Cancer | Liver Metastases

Germany, France
Nantes University Hospital

Completed

Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma (RIT in MTC)

Thyroid Neoplasms

France
UCB Pharma

Terminated

Study of Epratuzumab in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, Belgium, Netherlands, United Kingdom, Spain, Hungary
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Biosynexus Incorporated

Completed

Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis

Staphylococcal Sepsis

United States
Seagen Inc.

Terminated

Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer

Ovarian Neoplasms

United States
Abbott

Withdrawn

Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

Moderate to Severe Plaque Psoriasis
Halozyme Therapeutics

Completed

A Study of the Subcutaneous Injection of a Viscous Antibody Solution With Recombinant Human Hyaluronidase

Healthy
Eli Lilly and Company

Completed

A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available

Advanced Solid Tumors

United States
Seagen Inc.

Completed

A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndrome (MDS)

United States
NasVax Ltd

Unknown

Assessment of the Natural Antibody Response to Pneumococcal Surface Proteins During Acute Otitis Media in Children

Acute Otitis Media

Israel
Shanghai CP Guojian Pharmaceutical Co., Ltd.

Completed

Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer

Metastatic Breast Cancer

China
Creighton University
Genentech, Inc.

Unknown

Effect of Xolair on Airway Hyperresponsiveness

Allergic Asthma

United States
Bandim Health Project
Novo Nordisk A/S; Danish Council for Development Research; Fonden til Lægevidenskabens... and other collaborators

Completed

Long-term Follow-up of Measles Antibodies

Measles

Guinea-Bissau
Jiangsu Province Centers for Disease Control and...

Completed

Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young Children

Hand, Foot and Mouth Disease | Anti-EV71 | Anti-CVA16

China
Southern Europe New Drug Organization
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Unknown

Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)

Lymphoma, Mantle-Cell

Italy
Assistance Publique - Hôpitaux de Paris

Completed

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years (CORTAGE)

Vasculitis | Wegener's Granulomatosis | Microscopic Polyangiitis | Churg-Strauss Syndrome | Polyarteritis Nodosa

France
Novartis

Completed

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Type 2 Diabetes Mellitus | Impaired Glucose Tolerance

United States, Canada, Finland, Australia, Germany, India, Italy
National Institute of Neurological Disorders and...

Completed

Rituximab to Treat Stiff Person Syndrome

Stiff Person Syndrome

United States
Hospital Universitario Marqués de Valdecilla
Schering-Plough

Unknown

Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica

Polymyalgia Rheumatica

Spain

Search clinical trials for: anti-EGFR monoclonal antibody

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations